… (NSCLC), of which adenocarcinoma (ADC) and squamous cell carcinoma (SqCC) are the …
lung cancer (3), the association is higher in lung SqCC and small cell lung cancer than in lung …

… Precision medicine is becoming the standard of care in anti-cancer treatment. The
personalized precision management of cancer patients highly relies on the improvement of new …

… -small cell lung cancer (NSCLC) accounts for approximately 85% of cases and includes
adenocarcinoma and squamous cell carcinoma (among others), while small cell lung cancer (…

… results of the American College of Surgeons Oncology Group Z0050 trial: the utility of
positron emission tomography in staging potentially operable non-small cell lung cancer. …

… in non-small cell lung cancers and it is very much less frequent in small cell lung cancer, …
The personalized precision management of cancerous patients is highly dependent on the …

… Precision medicine has revolutionized the treatment of advanced non-small cell lung cancer
(NSCLC). Due to the discovery of novel predictive biomarkers, an exhaustive molecular …

… of computed tomography and lung cancer screening, the incidence of multiple primary lung
cancer, that is, the occurrence of two or more primary malignant lung tumors in a patient, has …

… malignant nodules clinically relevant to lung cancer from benign nodules 1,2 . Despite
numerous efforts, lung cancer persists as a predominant malignant tumor in terms of mortality rate …

… Lung cancer stands as one of the leading global causes of mortality, and surgical resection
… in managing early and locally advanced non-small cell lung cancer (NSCLC). Despite the …

… of lung cancer at tumor progression. A LB at diagnosis of late stage non-small cell lung
carcinoma (… of genomic alterations in lung cancer patients with tumor progression, but also at …